Table of Content - Tissue Plasminogen Activator Market

Tissue plasminogen activator (tPA) is an enzyme associated with the disintegration of blood clots. It is a serine protease present in endothelial cells. With the help of serine protease, the conversion of plasminogen to plasmin is catalyzed. Serine protease is a major enzyme for clot disintegration.

Market Dynamics

The increasing prevalence of ischemic strokes is expected to drive growth of the global tissue plasminogen activator market over the forecast period. For instance, Institute for Health Metrics and Evaluation report published in 2019, ischemia heart stroke accounted for around 63.5 million (95% UI 57·8–69·0) people globally. Ischemic stroke was responsible for 3.29 million (2·97–3·54) deaths in 2019 globally, with 3.45 million (2·96–4·03) incident cases in males and 4.19 million (3·61–4·91) in females.

Key features of the study:

This report provides in-depth analysis of the global tissue plasminogen activator market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2020 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global tissue plasminogen activator market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include F. Hoffmann-La Roche AG, Boehringer Ingelheim GmbH, CHIESI Farmaceutici S.p.A., Gennova Biopharmaceuticals Ltd, Abbott Laboratories, and Reliance Life Sciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global tissue plasminogen activator market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tissue plasminogen activator market

Detailed Segmentation:

Global Tissue Plasminogen Activator Market, By Drug Type:
- Alteplase
- Reteplase
- Tenecteplase
Global Tissue Plasminogen Activator Market, By Application:
- Ischemic Stroke
- Myocardial Infarction
- Pulmonary Embolism
- Thrombolysis
- Others
Global Tissue Plasminogen Activator Market, By Region:
- North America
  - By Drug Type
    - Alteplase
    - Reteplase
    - Tenecteplase
  - By Application
    - Ischemic Stroke
    - Myocardial Infarction
    - Pulmonary Embolism
    - Thrombolysis
    - Others
  - By Country
    - U.S.
    - Canada
- Latin America
  - By Drug Type
    - Alteplase
    - Reteplase
    - Tenecteplase
  - By Application
    - Ischemic Stroke
    - Myocardial Infarction
    - Pulmonary Embolism
    - Thrombolysis
    - Others
  - By Country
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - By Drug Type
    - Alteplase
    - Reteplase
    - Tenecteplase
  - By Application
    - Ischemic Stroke
    - Myocardial Infarction
    - Pulmonary Embolism
    - Thrombolysis
    - Others
  - By Country
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - By Drug Type
    - Alteplase
    - Reteplase
    - Tenecteplase
  - By Application
    - Ischemic Stroke
    - Myocardial Infarction
    - Pulmonary Embolism
    - Thrombolysis
    - Others
  - By Country
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - By Drug Type
    - Alteplase
    - Reteplase
    - Tenecteplase
  - By Application
    - Ischemic Stroke
    - Myocardial Infarction
    - Pulmonary Embolism
    - Thrombolysis
    - Others
  - By Country
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - By Drug Type
    - Alteplase
    - Reteplase
    - Tenecteplase
  - By Application
    - Ischemic Stroke
    - Myocardial Infarction
    - Pulmonary Embolism
    - Thrombolysis
    - Others
  - By Country/Region
    - South Africa
    - Central Africa
    - North Africa
Company Profiles
- F. Hoffmann-La Roche AG *
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Boehringer Ingelheim GmbH
- CHIESI Farmaceutici S.p.A.
- Gennova Biopharmaceuticals Ltd
- Abbott Laboratories
- Reliance Life Sciences

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Drug Type
  - Market Snippet, By Application
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Market Trend
- Epidemiology
- Key Developments
- Regulatory Scenario
- PEST Analysis
- Pipeline Analysis
- Acquisition and Collaboration Scenario
Global Tissue Plasminogen Activator Market– COVID-19 Impact Analysis
- COVID-19 Epidemiology
- Overall Impact on Healthcare Sector
- Total Impact of COVID-19 on Global Tissue Plasminogen Activator Market
- Government Recommendations
Global Tissue Plasminogen Activator Market, By Drug Type, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019–2030
  - Segment Trends
- Alteplase
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 -2030, (US$ Bn)
  - Segment Trends
- Reteplase
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
  - Segment Trends
- Tenecteplase
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
  - Segment Trends
Global Tissue Plasminogen Activator Market, By Application, 2018–2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019–2030
  - Segment Trends
- Ischemic Stroke
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
  - Segment Trends
- Myocardial Infarction
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
  - Segment Trends
- Pulmonary Embolism
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
  - Segment Trends
- Thrombolysis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
  - Segment Trends
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
  - Segment Trends
Global Tissue Plasminogen Activator Market, By Region, 2018–2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019–2030
  - Segment Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018–2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 –2030, (US$ Bn)
    - U.S.
    - Canada
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018–2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 –2030, (US$ Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018–2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 –2030, (US$ Bn)
    - China
    - Japan
    - India
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018–2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 –2030, (US$ Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018–2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 –2030, (US$ Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018–2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 –2030, (US$ Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Heat Map Analysis
- Company Profiles
  - F. Hoffmann-La Roche AG
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Boehringer Ingelheim GmbH
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - CHIESI Farmaceutici S.p.A.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Gennova Biopharmaceuticals Ltd
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Abbott Laboratories
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Reliance Life Sciences
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
Section
- References
- Research Methodology
- About us and Sales Contact

*Browse 26 market data tables and 29 figures on “Global Tissue Plasminogen Activator Market”– Global forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount